On 20 November 2026, WEIGAO GROUP (01066.HK) said the Exchange approved listing of 48.3 million H Shares converted from unlisted shares held by nine shareholders.
On 20 November 2026, ROKAE ROBOTICS (03752.HK) said it will seek an A Share listing on the Shenzhen Stock Exchange and has filed pre-listing tutoring.
On 20 November 2026, DOBOT (02432.HK) said its trustee bought 200,000 H shares for about HKD 2.87 million, lifting total holdings to roughly 1.4 million shares.
On 20 November 2026, Sipai Health (00314.HK) said its board adopted the 2026 Share Award Scheme, funded solely by existing shares purchased on-market by the trustee with no new shares issued and no options granted, capped at 5% of issued shares, with 1% per participant in 12 months and no shareholder approval needed.
On 20 November 2026, Xunce (03317.HK) said it will be included as a constituent of the Hang Seng TECH Index from 7 December 2026, per the announcement published by Hang Seng Indexes on the same day. The board expects the inclusion to broaden its investor base and enhance H-share liquidity and investment value.
On 20 November 2026, LIAONING PORT (02880.HK) launched a new Yingkou-Taicang domestic container liner service with sailings from its Yingkou port area.
On 20 November 2026, METIS TECHBIO-P (07666.HK) planned an on-market H-share buyback of up to HKD 300 million under a general mandate, using internal funds.
On November 20, 2026, BRAINAURORA-B topped the gainers with a rise of 39.50%; Z.AI led liquidity with turnover of HKD 2.198 billion. On the lock-up front, the lock-ups of TOPNC and UISEE TECH expired today, while TENNOR THERAP-B will see its lock-up expire on November 22.
On 19 November 2026, BRAINAURORA-B (06681.HK) said its DELIGHT study appeared in eClinicalMedicine, showing cognitive training improved heart and brain metrics.
On 19 November 2026, TRANSTHERA-B (02617.HK) converted 44,971,128 unlisted shares into H shares, lifting the H share proportion to 87.70% of 408,578,633 shares.
On 19 November 2026, FUDANZHANGJIANG (01349.HK) said NMPA accepted its filing for aminolevulinic acid hydrochloride granules used in bladder cancer surgery.
On November 19, 2026, KEYTOP PARKING topped the gainers with a rise of 34.06%; ILUVATAR COREX led liquidity with turnover of HKD 2.351 billion; TOPNC, UISEE TECH and TENNOR THERAP-B will see lock-up expiries this week.
Zhihu-W closed at HKD 6.440 on Nov 19, down 0.23%. Founder Zhou Yuan's family trust, with Vistra Trust (Singapore) as trustee, holds 100% of Class B shares.
INGENIC (03223.HK) fell 2.55% to HKD 74.400 on Nov 19 and is down 28.87% since joining Stock Connect on Sep 21; it is 25.60% below its HKD 100.00 offer price.
On 19 November 2026, ABBISKO-B (02256.HK) said preclinical data for its selective CDK4 inhibitor ABSK192 were shown as a poster at the 2026 ENA conference.
On 18 November 2026, BIDU-SW (09888.HK) granted 2,476,960 restricted shares to employees at nil purchase price, with the Class A shares closing at HK$ 70.2.















